Mesenchymal Stem Cell
9
0
2
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
22%
2 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (9)
Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
Stem Cell Therapy for Intracerebral Hemorrhage
MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients
Mesenchymal Stem Cells in Rotator Cuff Repair
Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis
Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection